1. Envisaged for implantation into the receptacle (14) adapted to expand radially, having at least one surface (16) of the metal stent (10) which in the expanded condition in the vessel (14) adjacent to its inside wall ( 15), the stent (10) is provided supported on the surface (16) with a mixture of bioresorbable binding agent based on lactic and glycolic acids, and the active substance, characterized in that the bioresorbable binding agent is an oligomer based on lactic and glycolic acids, chains whose length is short enough so that the biological decomposition of the oligomer occurs in the implanted state for about 6 nedel.2. The stent of claim. 1, characterized in that the oligomer is an oligo (D, L-lactate-co-glycolate) .3. The stent of claim. 2, characterized in that the oligomer has a molecular weight (M), of from 1000 to 4000 dalton.4. The stent of claim. 3, characterized in that the oligomer has a molecular weight (M), amounting to about 3000 dalton.5. The stent of claim 2, wherein the monomer ratio of lactic and glycolic acid oligomer is about 1:. 1.6. The stent of claim 3, wherein the monomer ratio of lactic and glycolic acid oligomer is about 1:. 1.7. . The stent of claim 4, wherein the monomer ratio of lactic and glycolic acid oligomer is about 1: 1.8. A stent according to one of claims. 1-7, wherein the binder and the active substance in the coating is a weight ratio of 3: 1 to 1: 3, preferably about 1: 1.9. A stent according to one of claims. 1-7, characterized in that the active1. Предусмотренный для имплантации в сосуд (14), выполненный с возможностью расширения в радиальном направлении, имеющий по меньшей мере одну поверхность (16) из металла стент (10), который в расширенном состоянии в сосуде (14) прилегает внутри к его стенке (15), причем стент (10) снабжен нанесенной на его поверхность (16) смесью из биорезорбируемого связывающего вещества на основе молочной и гликолевой кислот, а также активной субстанции, отличающийся тем, что биорезорбируемое
